Literature DB >> 23135062

Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.

.   

Abstract

This report summarizes current (as of 2011) guidelines or recommendations published by multiple agencies of the U.S. Department of Health and Human Services (DHHS) for prevention and control of human immunodeficiency virus (HIV) infection, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for persons who use drugs illicitly. It also summarizes existing evidence of effectiveness for practices to support delivery of integrated prevention services. Implementing integrated services for prevention of HIV infection, viral hepatitis, STDs, and TB is intended to provide persons who use drugs illicitly with increased access to services, to improve timeliness of service delivery, and to increase effectiveness of efforts to prevent infectious diseases that share common risk factors, behaviors, and social determinants. This guidance is intended for use by decision makers (e.g., local and federal agencies and leaders and managers of prevention and treatment services), health-care providers, social service providers, and prevention and treatment support groups. Consolidated guidance can strengthen efforts of health-care providers and public health providers to prevent and treat infectious diseases and substance use and mental disorders, use resources efficiently, and improve health-care services and outcomes in persons who use drugs illicitly. An integrated approach to service delivery for persons who use drugs incorporates recommended science-based public health strategies, including 1) prevention and treatment of substance use and mental disorders; 2) outreach programs; 3) risk assessment for illicit use of drugs; 4) risk assessment for infectious diseases; 5) screening, diagnosis, and counseling for infectious diseases; 6) vaccination; 7) prevention of mother-to-child transmission of infectious diseases; 8) interventions for reduction of risk behaviors; 9) partner services and contact follow-up; 10) referrals and linkage to care; 11) medical treatment for infectious diseases; and 12) delivery of integrated prevention services. These strategies are science-based, public health strategies to prevent and treat infectious diseases, substance use disorders, and mental disorders. Treatment of infectious diseases and treatment of substance use and mental disorders contribute to prevention of transmission of infectious diseases. Integrating prevention services can increase access to and timeliness of prevention and treatment.

Entities:  

Mesh:

Year:  2012        PMID: 23135062

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  95 in total

1.  Program collaboration and service integration in the prevention and control of HIV infection, viral hepatitis, STDs, and tuberculosis in the U.S.: lessons learned from the field.

Authors:  Kevin A Fenton; Gustavo A Aquino; Hazel D Dean
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

2.  Program collaboration and service integration activities among HIV programs in 59 U.S. health departments.

Authors:  Lauren F Fitz Harris; Lauren Toledo; Erica Dunbar; Gustavo A Aquino; Steven R Nesheim
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

3.  Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000-2013.

Authors:  Taraz Samandari; Ellen Tedaldi; Carl Armon; Rachel Hart; Joan S Chmiel; John T Brooks; Kate Buchacz
Journal:  Open Forum Infect Dis       Date:  2017-06-10       Impact factor: 3.835

4.  Trends in HIV Infection Among Persons Who Inject Drugs: United States and Puerto Rico, 2008-2013.

Authors:  Andrew John Mitsch; H Irene Hall; Aruna Surendera Babu
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

Review 5.  Antiretroviral therapy for prevention is a combination strategy.

Authors:  Margaret L McNairy; Myron Cohen; Wafaa M El-Sadr
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

6.  Managing tuberculosis in people who use and inject illicit drugs.

Authors:  Haileyesus Getahun; Annabel Baddeley; Mario Raviglione
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

7.  The opioid epidemic in rural northern New England: An approach to epidemiologic, policy, and legal surveillance.

Authors:  Thomas J Stopka; Erin Jacque; Patsy Kelso; Haley Guhn-Knight; Kerry Nolte; Randall Hoskinson; Amanda Jones; Joseph Harding; Aurora Drew; Anne VanDonsel; Peter D Friedmann
Journal:  Prev Med       Date:  2019-05-31       Impact factor: 4.018

8.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

9.  Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Authors:  Jason Grebely; Geert Robaeys; Philip Bruggmann; Alessio Aghemo; Markus Backmund; Julie Bruneau; Jude Byrne; Olav Dalgard; Jordan J Feld; Margaret Hellard; Matthew Hickman; Achim Kautz; Alain Litwin; Andrew R Lloyd; Stefan Mauss; Maria Prins; Tracy Swan; Martin Schaefer; Lynn E Taylor; Gregory J Dore
Journal:  Int J Drug Policy       Date:  2015-07-17

10.  Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009.

Authors:  Alia A Al-Tayyib; Hanne Thiede; Richard D Burt; Stephen Koester
Journal:  Prev Sci       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.